Clozapine Induced Neuroleptic Malignant Syndrome
- PMID: 31723648
- PMCID: PMC6786734
- DOI: 10.4266/kjccm.2016.00052
Clozapine Induced Neuroleptic Malignant Syndrome
Abstract
Neuroleptic malignant syndrome is a rare, but potentially life-threatening adverse event associated with the use of neuroleptic agents. We describe the case of a 47-year-old schizophrenic woman who was treated with clozapine for years. The patient developed acute renal failure with pulmonary edema, and underwent mechanical ventilation and hemodialysis.
Keywords: acute kidney injury; clozapine; neuroleptic malignant syndrome; rhabdomyolysis.
Copyright © 2017 The Korean Society of Critical Care Medicine.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Delay J, Pichot P, Lemperiere T, Elissalde B, Peigne F. A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses. Ann Med Psychol (Paris) 1960;118:145–52. - PubMed
-
- Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry. 1989;50:18–25. - PubMed
-
- Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77:185–202. - PubMed
-
- Strawn JR, Keck PE, Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164:870–6. - PubMed
Publication types
LinkOut - more resources
Full Text Sources